Today: 1 July 2026
Ashtead share price slips as AHT flags fresh buyback, NYSE move stays in focus
19 January 2026
1 min read

Ashtead share price slips as AHT flags fresh buyback, NYSE move stays in focus

London, Jan 19, 2026, 09:11 GMT — Regular session

  • Ashtead shares fell roughly 1.1% in early London trading
  • The company announced an additional tranche of buybacks as part of its $1.5 billion programme
  • Traders are eyeing the dividend election deadline on Jan 23, with the next buyback phase set for March

Ashtead Group (AHT) shares dropped roughly 1.1% to about 5,240 pence by 08:56 GMT, trailing the wider UK market’s modest decline. The FTSE 100 equipment rental company, known for its Sunbelt and A-Plant brands, has consistently repurchased its own stock.

The company bought back 71,535 shares on Jan. 16 at an average price of 5,310.3268 pence each, with individual trades between 5,274 and 5,342 pence. These shares were placed into treasury—meaning they were held rather than cancelled—leaving 416,170,962 shares outstanding excluding the treasury stock, and 35,183,871 shares held in treasury.

Why this matters now: Ashtead is closing in on completing its $1.5 billion buyback, launched in December 2024, with the current programme expected to wrap up by the end of February. In December’s results, CEO Brendan Horgan confirmed a fresh $1.5 billion buyback starting 2 March 2026 and said the NYSE re-listing “remains on track.” The company also set a Jan. 23 deadline for shareholders to opt for receiving the interim dividend in U.S. dollars, ahead of the Feb. 6 payment. Investegate

Buybacks can support a stock by reducing the number of shares outstanding, potentially boosting earnings per share if profits remain steady. However, they don’t affect the core rental demand that sustains the business.

Despite being listed in London, investors often treat Ashtead as if it’s a U.S. cyclical play. Its rental fleets move in step with construction and industrial spending, and shifts in “local” non-residential activity can quickly alter the outlook.

There’s a downside risk too. Should end-markets weaken more or the listing shift drag out, even a steady buyback won’t guarantee the stock won’t slip further.

Traders are focused on daily repurchase disclosures, looking for clues about how fast the programme is moving. They’re also waiting to see if management provides any new details about the New York move as March nears.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Galderma Shares Drop on FDA Denial of Relfydess Botox Rival
    July 1, 2026, 4:28 AM EDT. Galderma Group AG shares dropped sharply, posting their steepest fall in more than a year after the FDA turned down its Botox competitor Relfydess. Investors sold on news of the decision, worrying about Galderma's push into the Botox segment. The move is a setback for the Swiss company's plans to grow in the cosmetic treatment market.
Glencore share price rises as China scrutiny hangs over Rio Tinto merger talks
Previous Story

Glencore share price rises as China scrutiny hangs over Rio Tinto merger talks

OpenAI CFO Sarah Friar lifts lid on $20B revenue run rate as 2026 shifts to “practical adoption”
Next Story

OpenAI CFO Sarah Friar lifts lid on $20B revenue run rate as 2026 shifts to “practical adoption”

Go toTop